A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression

Journal of Psychiatric Research

Volumn 44, Issue 6, 2010, Pages 356-363

  Dubé, Sanjay ^a,b   Dellva, Mary Anne ^a   Jones, Marcia ^a   Kielbasa, William ^a   Padich, Robert ^a   Saha, Amitabh ^a   Rao, Prasad ^c  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Asha Hospital   (India)

Author keywords

LY2216684; Major depressive disorder; Norepinephrine reuptake inhibitor

Indexed keywords

ESCITALOPRAM; LY 2216684; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FATIGUE; FEMALE; GASTRITIS; GASTROENTERITIS; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALARIA; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE ATTEMPT; TACHYCARDIA; XEROSTOMIA;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CONSTIPATION; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; NAUSEA; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME; XEROSTOMIA; YOUNG ADULT;

EID: 77950944964     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.09.013     Document Type: Article

References (13)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. fourth ed. Text revision.
2. Greden J.F. The burden of disease for treatment-resistant depression. Journal of Clinical Psychiatry 2001, 62(Suppl. 16):26-31.
3. Greden J.F. Unmet need: what justifies the search for a new antidepressant?. Journal of Clinical Psychiatry 2002, 63(Suppl. 2):3-7.
4. Hajós M., Fleishaker J.C., Filipiak-Reisner J.K., Brown M.T., Wong E.H. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Reviews 2004, 10:23-44.
5. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
6. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders 1998, 50:97-108.
7. Khan A., Detke M.J., Khan S.R.F., Mallinckrodt C. Placebo response and antidepressant clinical trial outcome. The Journal of Nervous and Mental Disease 2003, 191:211-218.
8. Michelson D., Adler L.A., Amsterdam J.D., Dunner D.L., Nierenberg A.A., Reimherr F.W., et al. Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry 2007, 68:582-587.
9. The global burden of disease. WHO and World Bank 1996, Harvard School of Public Health, Boston. C.J.L. Murray, A.D. Lopez (Eds.).
10. Potter W.Z., Padich R.A., Rudorfer M.V., Krishnan K.R.R. Tricyclics, tetracyclics, and monoamine oxidase inhibitors. The American psychiatric publishing textbook of mood disorders 2006, 251-261. American Psychiatric Publishing, Washington, DC. D.J. Stein, D.J. Kupfer, A.F. Schatzberg (Eds.).
11. Sartorius N., Angstt J. Suicide in population subgroups. International Clinical Psychopharmacology 2001, 16(Suppl. 2:2p preceding S1).
12. Sheehan D.V., Lecrubier Y., Harnett-Sheehan K., Amorim P., Janavs J., Weiller E., et al. The mini international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. Journal of Clinical Psychiatry 1998, 59(Suppl. 20):22-33.
13. Sheiner L.B., Beal S.L. NONMEM users guide: NONMEM project group 2006, University of California, San Francisco.